Mit den International Expert Talks bietet die DOG in 2021 wiederum ein bewährtes englischsprachiges Programmformat. In einer Vortragsreihe werden renommierte, internationale Referenten Fragestellungen zu aktuellen Themen aus den verschiedenen Themengebieten und Subspezialitäten der Augenheilkunde beleuchten. Nach jedem Vortrag steht hinreichend Zeit zur Verfügung, die Inhalte in einer Diskussion zu vertiefen.
Wissenschaftliche Leitung: Claus Cursiefen (Köln), Berthold Seitz (Homburg/Saar)
Moderatorenteam: Gerd Auffarth (Heidelberg), Claus Cursiefen (Köln), Thomas Dietlein (Köln), Sascha Fauser (Basel), Matthias Fuest (Aachen), Rafael Grajewski (Köln), Michael Hoffmann (Magdeburg), Antonia Joussen (Berlin), Thomas Kohnen (Frankfurt), Wolf Lagrèze (Freiburg), Clemens Lange (Freiburg), Norbert Pfeiffer (Mainz), Uwe Pleyer (Berlin), Siegfried Priglinger (München), Frank Schaeffel (Tübingen), Berthold Seitz (Homburg/Saar), Hagen Thieme (Magdeburg), Marius Ueffing (Tübingen)
Freitag, 01.10.2021, 12:00 – 12:45 Uhr
New developments in limbal stem cell transplantation
Sayan Basu (Hyderabad, IND)
Limbal stem cell transplantation has evolved tremendously in the last two to three decades. This presentation will succinctly summarize the recent advances in diagnosis and management of limbal stem cell deficiency.
Freitag, 01.10.2021, 14:00 – 14:45 Uhr
Presbyopia correction with intraocular lenses: where are we in 2021
Rita Mencucci (Firenze, I)
The talk will present the different alternatives for presbyopia correction with intraocular lenses: monofocal lenses and monovision technique, refractive and diffractive multifocal lenses, the most recent extended depth of focus (EDOF) lenses.
There is no single lens that suits the needs of all patients: each technology has its advantages, disadvantages and limitations that it is necessary to know to advice our patients properly.
Today cataract surgery can also be considered a refractive procedure, with the aim to restore not only visual acuity, but also visual quality and quality of life.
Freitag, 01.10.2021, 16:00 – 16:45 Uhr
Update pathogenesis, diagnosis progression monitoring and therapy in dry AMD
Caroline Klaver (Rotterdam, NL))
Freitag, 01.10.2021, 18:00 – 18:45 Uhr
Which glaucoma surgery will stand the test of time?
Keith Barton (London, GB)
With increasing innovation in glaucoma surgery, there are many new procedures that are minimally invasive with fewer potential risks than traditional glaucoma surgery. What are the factors that will determine the long term use of glaucoma surgical procedures? Will it be ease of performance, safety, efficacy or surgeon training?
Samstag 02.10.2021, 10:00 – 10:45 Uhr
Myopia: treatment options beyond atropine eyedrops?!
Chi-Ho To (Hong Kong, HK)
Myopia is in epidemic proportion in East Asia and it is also becoming prevalent in the Western world. Since myopia, especially high myopia, increases the risk of sight-threatening eye diseases, a clinical solution is urgently needed. In this talk, I will share a translational research journey from the bench to the bedside in the search for optical solutions to myopia.
Samstag 02.10.2021, 13:00 – 13:45 Uhr
Visual field progression analysis in glaucoma
N.M. (Nomdo) Jansonius (Groningen, NL)
Perimetry shows significant variability but, paradoxically, it is also the unbeaten tool for monitoring progression in glaucoma. Knowledge on variability and disease progression is combined and translated into practical clinical rules for maximizing information from perimetry with minimal efforts.
Samstag 02.10.2021, 16:00 – 16:45 Uhr
Frank Price (Indianapolis, USA)
Since 2001, we have seen a shift from virtually all corneal transplants being penetrating keratoplasty to most grafts now being lamellar surgery. The shift is continuing as visual results, decreased complications, and enhanced surgical techniques allow more cases to be lamellar grafts. Recent advances will be discussed.
Samstag 02.10.2021, 18:00 – 18:45 Uhr
New developments in anti VEGF therapy in retinal diseases
Lloyd Paul Aiello (Boston, USA)
The discovery of vascular endothelial growth factor (VEGF) and its role in ischemic retinal vascular disorders resulted in major therapeutic advancements for several leading causes of blindness. VEGF inhibitors rapidly became the primary treatment of choice for diabetic macular edema, supplanting laser photocoagulation and resulting in less visual loss and more visual gain. Recently, we have now found that VEGF inhibition is also an appropriate treatment option for proliferative diabetic retinopathy and for nonproliferative diabetic retinopathy to prevent progression to sight threatening disease. These recent advances and new care paradigms will be discussed.
Sonntag 03.10.2021, 10:30 – 11:15 Uhr
Cataract surgery and perioperative management in uveitis-patients
Soon-Phaik Chee (Singapur, SGP)
The perioperative management of a uveitic cataract is as important as performing good surgery in these challenging eyes. Proper preoperative assessment, planning, counselling and preparation are key to success. Techniques for handling synechiae, pupillary membranes and small pupils atraumatically will be shown.
Sonntag 03.10.2021, 13:30 – 14:15 Uhr
Update on Central Serous Chorioretinopathy: New interpretation of an old disease
Camiel Boon (Leiden, NL)
Central serous chorioretinopathy is an intriguing chorioretinopathy, that is surrounded by controversy in terms of pathogenesis, classification, and treatment. This presentation will give an update on key new insights into this mysterious disease.